Product Images Nivestym
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 44 images provide visual information about the product associated with Nivestym NDC 0069-0292 by Pfizer Laboratories Div Pfizer Inc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
The text contains only two fragments of text which are not enough to provide a useful description. The first fragment includes the characters "P zer" and the second fragment includes the word "Oncology". Without further context, it is not possible to generate a description or to infer what the text is referring to.*
This text describes an alcohol wipe cotton ball, an adhesive bandage, and a sharps disposal container, likely related to medical or first aid use.*
This appears to be a list of body parts including the stomach area, thigh, upper arm, and buttocks.*
Nivestym is a prescription drug that comes in a 1 mL single-dose vial. It contains filgrastim-aafi and is distributed by Pfizer Labs, a division of Pfizer Inc. It is recommended to store the medication at 2°C to 8°C. The dosage information can be found on the package. The drug is produced by Hospira, Inc. and is a biosimilar. The US License number for this medication is 1974.*
Nivestym is a medication that comes in the form of an injection with no preservatives. The provided text also contains various identification numbers, possibly for inventory or tracking purposes, and some illegible characters.*
This is a medication called Nivestym (filgrastim-aafi) Injection that is manufactured by Hospira, Inc. The dosage instructions are on the package. It is important to store it at 2°08°C. The medication comes in a 1.6 mL single-dose vial and is distributed by Pfizer Labs. This medication is a biosimilar. The text includes a reference number of RL10065.*
This text describes a medication called 'filgrastim-aafi' which is sold as a single dose in a syringe. It is for subcutaneous use only and produced by the company 'Hospialnc'. The medication has a concentration of 300mg/0.5mL and comes in a BTV container. The text includes a license number and a production date but does not include any information on the medical uses or side effects of the medication.*
This appears to be a product description for a single-dose prefilled syringe with a needle guard. The syringe contains a sterile solution with recombinant Granulocyte Colony Stimulating factor (G-CSF) derived from E. coli. It is for subcutaneous use only and should be discarded if unused. The product is called ivestym™ (filgrastim-aafi) Injection and comes in a 300 mogh.5ml dose.*
This appears to be the label or packaging information for a medication called "Neulastim" or "Filgrastim-aafi" for subcutaneous use only. It includes the manufacturer's name and license number, as well as production and expiration information, but does not provide information on the medication's purpose or effects.*
Nivestym is a sterile solution injection of 480 mcg/0.8 mL Filgrastim-aafi, a recombinant Granulocyte Colony Stimulating Factor derived from E. coli, for subcutaneous use only. It is a single-dose prefilled syringe with needle guard. The unused portion should be discarded, and the solution has no preservative.*
This appears to be a mixture of outputs and does not make a coherent description. The text does not appear to be readable and may need to be rescanned or checked for any errors during transcription.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.